These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 29311063
1. Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates. Bordallo-Cardona MÁ, Marcos-Zambrano LJ, Sánchez-Carrillo C, de la Pedrosa EGG, Cantón R, Bouza E, Escribano P, Guinea J. Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311063 [Abstract] [Full Text] [Related]
5. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations. Arendrup MC, Perlin DS, Jensen RH, Howard SJ, Goodwin J, Hope W. Antimicrob Agents Chemother; 2012 May; 56(5):2435-42. PubMed ID: 22354305 [Abstract] [Full Text] [Related]
7. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway. Singh A, Healey KR, Yadav P, Upadhyaya G, Sachdeva N, Sarma S, Kumar A, Tarai B, Perlin DS, Chowdhary A. Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199 [Abstract] [Full Text] [Related]
8. In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates. Bordallo-Cardona MÁ, Escribano P, de la Pedrosa EG, Marcos-Zambrano LJ, Cantón R, Bouza E, Guinea J. Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872063 [Abstract] [Full Text] [Related]
9. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382 [Abstract] [Full Text] [Related]
10. Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations. Lepak A, Castanheira M, Diekema D, Pfaller M, Andes D. Antimicrob Agents Chemother; 2012 Nov; 56(11):5875-82. PubMed ID: 22948870 [Abstract] [Full Text] [Related]
11. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait. Al-Baqsami ZF, Ahmad S, Khan Z. Sci Rep; 2020 Apr 10; 10(1):6238. PubMed ID: 32277126 [Abstract] [Full Text] [Related]
12. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance. Pham CD, Iqbal N, Bolden CB, Kuykendall RJ, Harrison LH, Farley MM, Schaffner W, Beldavs ZG, Chiller TM, Park BJ, Cleveland AA, Lockhart SR. Antimicrob Agents Chemother; 2014 Aug 10; 58(8):4690-6. PubMed ID: 24890592 [Abstract] [Full Text] [Related]
13. Analysis of fks1 and fks2 gene mutations in invasive Candida glabrata strains from Pakistan. Memon S, Ghanchi NK, Zafar U, Farooqi J, Zaka S, Jabeen K. Mycoses; 2023 Jan 10; 66(1):52-58. PubMed ID: 36106428 [Abstract] [Full Text] [Related]
14. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Zimbeck AJ, Iqbal N, Ahlquist AM, Farley MM, Harrison LH, Chiller T, Lockhart SR. Antimicrob Agents Chemother; 2010 Dec 10; 54(12):5042-7. PubMed ID: 20837754 [Abstract] [Full Text] [Related]
15. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS). Kritikos A, Neofytos D, Khanna N, Schreiber PW, Boggian K, Bille J, Schrenzel J, Mühlethaler K, Zbinden R, Bruderer T, Goldenberger D, Pfyffer G, Conen A, Van Delden C, Zimmerli S, Sanglard D, Bachmann D, Marchetti O, Lamoth F, Fungal Infection Network of Switzerland (FUNGINOS). Clin Microbiol Infect; 2018 Nov 10; 24(11):1214.e1-1214.e4. PubMed ID: 29909005 [Abstract] [Full Text] [Related]
16. MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata. Bordallo-Cardona MÁ, Agnelli C, Gómez-Nuñez A, Sánchez-Carrillo C, Bouza E, Muñoz P, Escribano P, Guinea J. Antimicrob Agents Chemother; 2019 Jan 10; 63(1):. PubMed ID: 30397068 [Abstract] [Full Text] [Related]
19. In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with FKS Mutations. Nunnally NS, Etienne KA, Angulo D, Lockhart SR, Berkow EL. Antimicrob Agents Chemother; 2019 Nov 10; 63(11):. PubMed ID: 31481447 [Abstract] [Full Text] [Related]
20. Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance. Shields RK, Nguyen MH, Press EG, Updike CL, Clancy CJ. Antimicrob Agents Chemother; 2013 Dec 10; 57(12):6361-5. PubMed ID: 24060873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]